Clinical Trials Data Presentation 
Cannabis Law Report
JUNE 4, 2021
(Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The full presentation is available at: [link]. Highlights from the presentation include: Declining PSA levels in treated patients.
Cannabis Law Report
DECEMBER 2, 2021
IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
JANUARY 11, 2023
Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. Keen to learn more about the trial and Gaize’s innovative product, I asked CEO Ken Fichtler some questions. Here’s what he had to say.
Project CBD
FEBRUARY 27, 2023
Researchers have been investigating the use of cannabis to treat fibromyalgia’s constellation of symptoms for decades, with early clinical trials in the 2000s 1-4 suggesting a possible benefit of both pure THC and flower in managing the disease. It’s not a new idea. © Copyright, Project CBD.
The Cannigma
FEBRUARY 2, 2021
“Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.
Cannabis Law Report
DECEMBER 3, 2021
We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D.,
Otherside Farms
JANUARY 25, 2019
Lead author Dr. Tim England, honorary consultant stroke physician at the University of Nottingham and Royal Derby Hospital, presented the findings at this week’s annual UK Stroke Forum conference. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial.”.
Expert insights. Personalized for you.
100 
Let's personalize your content